The Pharmacogenomics Journal - Table of Contents alert Volume 16 Issue 1

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 16, Issue 1 (February 2016) In this issue Letter To The Editor Consensus Article Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe   Letter To The Editor Top Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis J E Megías-Vericat, L Rojas, M J Herrero, V Bosó, P Montesinos, F Moscardó, J L Poveda, M A Sanz and S F Aliño Pharmacogenomics J 2016 16: 1-2; advance online publication, October 27, 2015; 10.1038/tpj.2015.79 Full Text Consensus Article Top Common variants of the G protein-coupled receptor type 4 are associated with human essential hypertension and predict the blood pressure response to angiotensin receptor blockade H Sanada, M Yoneda, J Yatabe, S M Williams, J Bartlett, M J White, L N Gordon, R A Felder, G M Eisner, I Armando and P A Jose Pharmacogenomics J 2016 16: 3-9; advance online publication, March 3, 2015; 10.1038/tpj.2015.6 Abstract | Full Text Original Articles Top Meta-analysis reveals significant association of 3′-UTR VNTR in SLC6A3 with smoking cessation in Caucasian populations Y Ma, W Yuan, W Cui and M D Li Pharmacogenomics J 2016 16: 10-17; advance online publication, July 7, 2015; 10.1038/tpj.2015.44 Abstract | Full Text Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis E Cariani, L Roli, G Missale, E Villa, C Ferrari and T Trenti Pharmacogenomics J 2016 16: 18-29; advance online publication, April 28, 2015; 10.1038/tpj.2015.28 Abstract | Full Text A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia J E Megías-Vericat, M J Herrero, L Rojas, P Montesinos, V Bosó, F Moscardó, D Martínez-Cuadrón, J L Poveda, M Á Sanz and S F Aliño Pharmacogenomics J 2016 16: 30-40; advance online publication, December 8, 2015; 10.1038/tpj.2015.80 Abstract | Full Text Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapy S Cao, S Wang, H Ma, S Tang, C Sun, J Dai, C Wang, Y Shu, L Xu, R Yin, X Song, H Chen, B Han, Q Li, J Wu, C Bai, J Chen, G Jin, Z Hu, D Lu and H Shen Pharmacogenomics J 2016 16: 41-46; advance online publication, March 31, 2015; 10.1038/tpj.2015.22 Abstract | Full Text Effect of the CYP3A5 and ABCB1 genotype on exposure, clinical response and manifestation of toxicities from sunitinib in Asian patients Y L Teo, H L Wee, X P Chue, N M Chau, M-H Tan, R Kanesvaran, H L Wee, H K Ho and A Chan Pharmacogenomics J 2016 16: 47-53; advance online publication, March 17, 2015; 10.1038/tpj.2015.13 Abstract | Full Text Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study D J Crona, J Ramirez, W Qiao, A-J de Graan, M J Ratain, R H N van Schaik, R H J Mathijssen, G L Rosner and F Innocenti Pharmacogenomics J 2016 16: 54-59; advance online publication, April 14, 2015; 10.1038/tpj.2015.23 Abstract | Full Text Unravelling the transcriptomic landscape of the major phase II UDP-glucuronosyltransferase drug metabolizing pathway using targeted RNA sequencing A Tourancheau, G Margaillan, M Rouleau, I Gilbert, L Villeneuve, E Lévesque, A Droit and C Guillemette Pharmacogenomics J 2016 16: 60-70; advance online publication, April 14, 2015; 10.1038/tpj.2015.20 Abstract | Full Text A prospective randomized evaluation of a pharmacogenomic approach to antiplatelet therapy among patients with ST-elevation myocardial infarction: the RAPID STEMI study D Y F So, G A Wells, R McPherson, M Labinaz, M R Le May, C Glover, A J Dick, M Froeschl, J-F Marquis, M H Gollob, L Tran, J Bernick, B Hibbert and J D Roberts On behalf of the CAPITAL investigators Pharmacogenomics J 2016 16: 71-78; advance online publication, April 7, 2015; 10.1038/tpj.2015.17 Abstract | Full Text A non-synonymous polymorphism in galectin-3 lectin domain is associated with allergic reactions to beta-lactam antibiotics J A Cornejo-García, A Romano, R M Guéant-Rodríguez, A Oussalah, N Blanca-López, F Gaeta, D Tramoy, T Josse, I Doña, M J Torres, G Canto, M Blanca and J-L Guéant Pharmacogenomics J 2016 16: 79-82; advance online publication, April 14, 2015; 10.1038/tpj.2015.24 Abstract | Full Text HLA-B*59:01: a marker for Stevens–Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese F Yang, J Xuan, J Chen, H Zhong, H Luo, P Zhou, X Sun, L He, S Chen, Z Cao, X Luo and Q Xing Pharmacogenomics J 2016 16: 83-87; advance online publication, April 28, 2015; 10.1038/tpj.2015.25 Abstract | Full Text CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients B A Maganda, O M S Minzi, E Ngaimisi, A A R Kamuhabwa and E Aklillu Pharmacogenomics J 2016 16: 88-95; advance online publication, May 12, 2015; 10.1038/tpj.2015.37 Abstract | Full Text The role of Toll-like receptor 4 polymorphisms in vaccine immune response P Pellegrino, F S Falvella, S Cheli, C Perrotta, E Clementi and S Radice Pharmacogenomics J 2016 16: 96-101; advance online publication, March 31, 2015; 10.1038/tpj.2015.21 Abstract | Full Text The P2 promoter of the IGF1 gene is a major epigenetic locus for GH responsiveness OPEN M Ouni, M P Belot, A L Castell, D Fradin and P Bougnères Pharmacogenomics J 2016 16: 102-106; advance online publication, April 14, 2015; 10.1038/tpj.2015.26 Abstract | Full Text Using local multiplicity to improve effect estimation from a hypothesis-generating pharmacogenetics study W Zou and H Ouyang Pharmacogenomics J 2016 16: 107-112; advance online publication, March 24, 2015; 10.1038/tpj.2015.19 Abstract | Full Text   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.